PharmaBoardroom

Interview with Shuting Fang, President, China Association of…

You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia…

Interview with John Oyler, Founder and CEO, Bioduro

You’ve run a number of life sciences companies now, but before that you started Telephia, an information services provider to the wireless industry.…

Interview with Bill Guo, Chairman and Founder, Venturepharm

Venturepharm is the most diversified company we’ve seen, throughout many verticals, taking a full-service plus model from venture capital, merchant…

Interview with Howard Balloch, President, The Balloch Group

What initially attracted you to China and what kept you here over the years? I initially became interested in China during university where I studied…

Interview with Honggang BI, Corporate VP, General Manager,…

You have had significant experience at GSK and Pfizer, and also at Frontage Labs doing more entrepreneurial work. What ultimately brought you to…

Interview with Yu Peng, President, China Medicinal Biotech…

Could you please give us a brief introduction on CMBA? First and most obviously for new arrivals to our office, since 2011 we have changed locations,…

Interview: Michel Vounatsos – General Manager, MSD China

MSD China's Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and…

Interview with Eric Bouteiller, President, Beaufour IPSEN China

Your background before joining Beaufour Ipsen is quite unique among country managers of pharmaceutical companies: working many years in academia and…

Interview with James Qun Xue, Managing Director, Genzyme…

In 2006, Genzyme’s global CEO, Henri Termeer, said he is “personally very interested in China” and that he expects the company to build a…

Interview with Zheng Hong, Chairman, China Pharmaceutical…

You have a very long history in the Chinese pharmaceutical industry, first in the joint venture company Xian-Janssen and then in the China National…

Interview with Ricardo Glucksmann Meissner, General Manager,…

Maver has an impressive track record in developing and commercializing blockbuster products for the Chilean market, such as Tapsin and Disfruta, which…

Interview with Ricardo Aguilar, CPO Head & Country…

Novartis’ pharmaceutical activities include innovators, generics and biopharmaceuticals. How has your portfolio developed in Chile? What…

Tagged with